FDA Orange Book
Generic for Luxiq
Luxiq contains betamethasone valerate. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
Yes. The generic name for Luxiq is betamethasone valerate. 4 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB.
Run it in Rivvi
Map Luxiq and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Luxiq products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| aerosol, foam, topical | 0.12% | Discontinued | None | 4 | AB |
NDA 020934, held by QUAGEN PHARMACEUTICALS LLC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Approved generic betamethasone valerate
| Company | ANDA | TE code | Approved | Strengths |
|---|---|---|---|---|
| PADAGIS ISRAEL PHARMACEUTICALS LTD | 078337 | AB (A-rated, therapeutically equivalent) | November 26, 2012 | 0.12% |
| TARO PHARMACEUTICAL INDUSTRIES LTD | 208204 | AB (A-rated, therapeutically equivalent) | May 24, 2017 | 0.12% |
| XIROMED PHARMA ESPANA SL | 210639 | AB (A-rated, therapeutically equivalent) | April 18, 2023 | 0.12% |
| ALEMBIC PHARMACEUTICALS LTD | 215832 | AB (A-rated, therapeutically equivalent) | August 22, 2024 | 0.12% |
Questions
Is there a generic for Luxiq?
Yes. The generic name for Luxiq is betamethasone valerate. 4 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB.
What is the generic name for Luxiq?
The active ingredient in Luxiq is betamethasone valerate, per the FDA Orange Book.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.